Bibliometric analysis of pharmaceutical papers from Double First-rate universities in China
10.12206/j.issn.1006-0111.202106136
- VernacularTitle:我国双一流高校药学论文的文献计量分析
- Author:
Ruimin LI
1
;
Lijun CUI
1
;
Lixin SHU
1
;
Jing CHEN
1
Author Information
1. School of Pharmacy, Naval Medical University, Shanghai 200433, China.
- Keywords:
Double First-rate;
universities;
pharmacy;
bibliometrics
- From:
Journal of Pharmaceutical Practice
2021;39(4):331-335
- CountryChina
- Language:Chinese
-
Abstract:
Objective To understand the development status in the subject of pharmacy and provide recommendations for the construction of universities and the development of pharmacy by the bibliometric analysis of pharmaceutical papers from Double First-rate universities in China. Methods China National Knowledge Network (CNKI), Wanfang and VIP databases were searched for Chinese literature, and Scopus database was searched for English literature. Duplicates and non-research literatures were deleted. 12 028 literatures were included. Excel 2016 software was used for statistical analysis. Results From 2014 to 2019, the total number of papers published by Double First-rate universities increased year by year, with the highest increase rate of 14%. From 2014 to 2020, 11 178 papers were published in international journals, while only 850 were published in domestic journals. Nearly 93% of pharmaceutical papers flowed to foreign journals. Peking Union Medical College published the most papers in international journals. Sun Yat-sen University published the most SCI papers. Peking University published the most papers in domestic journals, while Fudan University published the highest number of papers in Q1 area. Only a few papers published with international coauthors from colleges or universities. The cooperation works were limited in the same province or municipality directly under the central government. Conclusion Double First-rate universities should focus on strengthening international cooperation and inter-provincial cooperation, improving industry-university collaboration, and accelerating the transformation from scholar research to productions.
